Join our community of smart investors

Shares I love: bioMérieux

bioMérieux invested early in PCR testing and this is now one of its fastest-growing segments
Shares I love: bioMérieux
  • One of bioMérieux's fastest-growing business segments is PCR tests
  • The company is well-placed to benefit from structural growth drivers such as the move towards personalised medicine and need to reduce healthcare costs

Lorna Logan, co-manager of Stewart Investors European Sustainability Fund (IE00BN2B0908), explains why she invests in French healthcare equipment company bioMérieux (FRA:BIM).

“bioMérieux makes testing equipment used to diagnose infectious diseases, screen for cancer and detect microorganisms in food, pharmaceutical and cosmetic products. The company has been a pioneer in the field of diagnostics for over 55 years with a steadfast mission to improve patient outcomes, increase laboratory efficiency and protect the health of people around the world.

To continue reading...
Join our Community of Smart Investors
  • Independent full-length company analysis
  • Actionable investment ideas and recommendations
  • Expert investment tools and data
  • Stock screens from Algy Hall
Have an account? Sign in